Amara Nwosu

MBCHB MRCP PhD

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours

Leave a comment

This is a review of 131I-MIBG therapy for metastatic neuroendocrine tumours published in the British Journal of Cancer.

http://www.nature.com/bjc/journal/v98/n6/full/6604273a.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s